Answers are grounded in this paper and cite their sources.
Analysis shows the need for clearer laws on general foods in capsule/tablet form, indicating consumer protection challenges.
Recently, as the number of general foods in the form of tablets and capsules has increased, the possibility of consumers mistaking or confusing them for medicines or health functional foods has increased. Currently, foods that can be labeled with functionality include health functional foods and foods with functional labels, and unlike health functional foods, foods with functional labels cannot be manufactured in capsule or tablet form. In addition, general foods that claim functionality by exploiting loopholes in regulations are rapidly increasing, so it can be said that systematic management is necessary for consumer protection. Article 2 of the Food Code, Common Standards and Specifications for General Foods, Article 2. Manufacturing and Processing Standards 11) stipulates that “Foods cannot be manufactured in the form of capsules or tablets. However, confectionery, candies, chewing gum, chocolate, soy sauce, seasoned foods, processed sugar products, beverages, and processed fruits and vegetables may be manufactured in tablet form, and edible oils and fats may be manufactured in capsule form. However, in this case, they must be manufactured so that there is no risk of mistake or confusion with medicines or health functional foods.” Thus, in principle, the manufacturing of general foods in the form of tablets or capsules is prohibited. However, the above food code regulations are only regulations to guarantee the consumer's right to know and establish a sound trade order, which are the legislative purposes of the Food Labeling and Advertising Act, and it is difficult to view them as regulations to protect and promote the health of the people, so it can be seen as an excess of the limits of delegated legislation. Although this regulation appears to be targeting general foods in the form of tablets and capsules that may be easily mistaken for or confused with medicines or health functional foods, what this regulation targets is labels or advertisements that may be mistaken for or confused with medicines or health functional foods. Therefore, the provisions of the Food Code, which stipulate the manufacturing and processing standards for general foods in the form of tablets and capsules, are subject to regulation of labeling or advertising that may cause confusion or misunderstanding of general foods in the form of tablets and capsules as medicines or health functional foods. Therefore, it can be said that this is a regulation that goes beyond the limits of delegated legislation, as the Commissioner of the Ministry of Food and Drug Safety stipulated in a public notice content that could not be stipulated in a public notice from the beginning, considering the legislative purpose of the legal provision and the content of the provision. On the other hand, general foods in the form of tablets or capsules are beneficial to consumers in many ways. In other words, since general foods in the form of tablets or capsules are beneficial to consumers, unlike what the Food Code stipulates, it is necessary to broadly (in principle) allow the manufacturing and processing of general foods in the form of tablets or capsules, if possible. Of course, even in this case, it is necessary to consider revising (legislating) the Food Code to prohibit the manufacturing and processing of general foods in the form of tablets or capsules that may be mistaken or confused with medicines or health functional foods, taking into account “consumer safety (protection and promotion of national health).” That is, within the scope of the purpose of delegated legislation of the Food Sanitation Act, it is necessary to consider revising Article 2 of the current Food Code, Common Standards and Specifications for General Foods, Article 2. Manufacturing and Processing Standards 11) to “Foods containing functional raw materials for medicines or health functional foods cannot be manufactured in the form of capsules or tablets.”
No takes yet. Share an insight, caveat, or question.
Eui-Geun Park (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: